Literature DB >> 18417525

Infliximab effective in steroid-dependent juvenile eosinophilic fasciitis.

N Tzaribachev, U Holzer, J Schedel, V Maier, R Klein, J Kuemmerle-Deschner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18417525     DOI： 10.1093/rheumatology/ken142

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

1.  Infliximab may be effective in the treatment of steroid-resistant eosinophilic fasciitis: report of three cases.

Authors:  Dinesh Khanna; Harsh Agrawal; Philip J Clements
Journal:  Rheumatology (Oxford)       Date:  2010-03-22       Impact factor: 7.580

2.  Refractory eosinophilic fasciitis successfully treated with infliximab: A case report.

Authors:  Paulina Śmigielska; Justyna Czarny; Jacek Kowalski; Aleksandra Wilkowska; Roman J Nowicki
Journal:  J Scleroderma Relat Disord       Date:  2021-03-26

Review 3.  Eosinophilic Fasciitis: an Updated Review on Diagnosis and Treatment.

Authors:  Daniel R Mazori; Alisa N Femia; Ruth Ann Vleugels
Journal:  Curr Rheumatol Rep       Date:  2017-11-04       Impact factor: 4.592
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.